Pharmacological effects of compounds of plant-derived compounds in chronic diseases

Authors

  • Yuan Feng

DOI:

https://doi.org/10.61173/r08p5p56

Keywords:

Plant-derived compounds, Chronic disease therapy, Pharmacological mechanisms

Abstract

Plant-derived compounds demonstrate significant potential in the prevention and treatment of chronic diseases due to their rich bioactivity and diverse pharmacological effects. Common active constituents include flavonoids, polyphenols, alkaloids, and terpenoids, which exert therapeutic effects through mechanisms such as antioxidant, anti-inflammatory, antitumour, and immunomodulatory actions. Research indicates that plant-derived compounds not only improve insulin sensitivity and regulate blood glucose levels in diabetic patients but also offer effective interventions for cardiovascular diseases, cancers, and neurodegenerative disorders. Compared to conventional pharmaceuticals, their multi-targeted action, low toxicity, and minimal side effects offer new possibilities for personalised treatment. However, their efficacy requires validation through large-scale clinical trials. Future efforts should focus on enhancing mechanism research, improving bioavailability, and advancing the application of big data and artificial intelligence in drug development to achieve precision medicine and clinical translation. Further exploration of interdisciplinary collaboration will offer novel approaches to chronic disease prevention and control. Concurrently, the development and utilisation of plant-derived compounds will play a significant role within sustainable healthcare systems.

References

[1] Elizabeth N, et al. Biosynthetic gene clusters, microbiomes, and secondary metabolites in cold water marine organisms. University of South Florida, 2020, November.

[2] Zulkipli I N, et al. Medicinal plants: A potential source of compounds for targeting cell division. Drug Target Insights, 2015, 9(1): 9–19.

[3] Cui H. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget, 2017, 8(41): 72064–72078.

[4] Khan H. Advancements in phytomedicine: Targeting multiple pathways in chronic disease management with plant-based compounds. Longdom Publishing S.L., 2024, December 31.

[5] Jin Z. Bioactive compounds associated with chronic disease prevention (master’s thesis). Cornell University, Cornell University Library, 2024, May.

[6] Nishad K, et al. Exploring the potential of natural compounds as chemotherapeutic agents: Challenges and opportunities. International Journal of Research Publication and Reviews, 2025, March.

[7] Bashir T, et al. The discovery of small chemical inhibitors for cancer treatment in plants: A review article. XISD Journal of Science & Technology, 2024, 20(10).

[8] Jyotsana M. Bioactive constituents of medicinal plants: Their mechanisms of action and role in disease prevention. International Journal of Scientific Research, 2025, 12(3), March.

[9] Panche A N, et al. Flavonoids: An overview. Journal of Dean&Francis ISSN 2959-409X Nutritional Science, 2016, 5: e47.

[10] Nakadate K, Ito N, Kawakami K, et al. Anti-inflammatory actions of plant-derived compounds and prevention of chronic diseases: From molecular mechanisms to applications. International Journal of Molecular Sciences, 2025, 26(11): 5206.

[11] Muthukaviya M, et al. Herbal remedies and phytomedicine. Zenodo, 2023, 02(01): 131–135, February 3.

[12] Ragini, et al. Anti-cancer compounds from medicinal plants: Isolation, identification, and characterization. International Journal of Biosciences, 2020, 17(6): 442–469.

[13] Kavitha S. Plant-based anti-inflammatory agents: A scientific review of bioactive compounds and mechanisms. Asian Journal of Biological and Life Sciences, 2025, 14(1), April.

[14] Lu J Q, Zhao Y X, Liu X T, et al. Research progress on the mechanisms of resveratrol in diabetes and its complications. Drug Evaluation Research, 2018, 41(2), February.

Downloads

Published

2025-12-19